Similar articles

• Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma.

  Ho HC, Kwan HC, Ng MH, de The G. Ho HC, et al. Lancet. 1978 Feb 25;1(8061):436. doi: 10.1016/s0140-6736(78)91220-5. Lancet. 1978. PMID: 75457 No abstract available.
• Epstein-Barr-specific IgA in nasopharyngeal cancer.

  [No authors listed] [No authors listed] Lancet. 1978 Jun 24;1(8078):1345-6. Lancet. 1978. PMID: 78104 No abstract available.
• Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.

  Henle W, Henle G, Ho JH. Henle W, et al. IARC Sci Publ (1971). 1978;(20):427-37. IARC Sci Publ (1971). 1978. PMID: 215525 No abstract available.
• [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].

  Mazeron MC. Mazeron MC. Bull Cancer Radiother. 1996;83(1):3-7. Bull Cancer Radiother. 1996. PMID: 8679277 Review. French.
• Nasopharyngeal carcinoma.

  Andersson-Anvret M, Forsby N, Klein G. Andersson-Anvret M, et al. Prog Exp Tumor Res. 1978;21:100-16. doi: 10.1159/000400860. Prog Exp Tumor Res. 1978. PMID: 205903 Review. No abstract available.